Advanced renal cell carcinoma
Conditions
Interventions
None listed
Sponsors
Department of Urology, Kindai University Faculty of Medicine
Osaka Urology Research Foundation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients on treatment with systemic therapy with targeted agents
Exclusion criteria
Exclusion criteria: Patients on treatment with systemic therapy with targeted agents as pre-surgical treatment prior to cytoreductive nephrectomy. Patients with cytokine therapy only.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Treatment duration for every systemic treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Objective response Time to response Time to progression Overall survival Adverse event profile | — |
Countries
Japan
Contacts
Public ContactMasahiro Nozawa
Kindai University Faculty of Medicine Urology
Outcome results
None listed